Senior corporate finance executive and investor-relations specialist with experience in cross-border M&A, capital markets and strategic finance. Debra Pladsen led treasury, investor communications and transaction execution at public and private companies, advising boards on capital structure, IPO readiness and liquidity management. Known for bridging operating teams and institutional investors, she has worked across technology and healthcare sectors and holds an MBA and BA in finance, positioning her for CFO/advisory roles or board-level oversight.
Senior corporate finance executive and investor-relations specialist with experience in cross-border M&A, capital markets and strategic finance. Debra Pladsen led treasury, investor communications and transaction execution at public and private companies, advising boards on capital structure, IPO readiness and liquidity management. Known for bridging operating teams and institutional investors, she has worked across technology and healthcare sectors and holds an MBA and BA in finance, positioning her for CFO/advisory roles or board-level oversight.
Seasoned corporate finance executive who prioritizes capital efficiency, liquidity management and investor transparency. Focuses on disciplined capital allocation that balances strategic M&A, IPO readiness and working-capital optimization to support durable growth. Employs a market-oriented lens bridging operating teams and institutional investors, favoring technology and healthcare opportunities where operational improvements and clear governance unlock value. Time horizon is medium-to-long; risk framework emphasizes stress-tested capital structures, transparent communication and board-aligned decision making.
Seasoned corporate finance executive who prioritizes capital efficiency, liquidity management and investor transparency. Focuses on disciplined capital allocation that balances strategic M&A, IPO readiness and working-capital optimization to support durable growth. Employs a market-oriented lens bridging operating teams and institutional investors, favoring technology and healthcare opportunities where operational improvements and clear governance unlock value. Time horizon is medium-to-long; risk framework emphasizes stress-tested capital structures, transparent communication and board-aligned decision making.
| Trades 505 | Longs Won 354/505 70% | Profit Factor 13.56 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $236,203.47 |
| Average Win $86,182.64 | Best Trade (Jun 30) $3.21M | Sharpe Ratio -10.34 |
| Average Loss -$14,905.31 | Worst Trade (Aug 19) -$785,914.5 | Z-Score 4.23 (100%) |
| Commissions $0 | Avg. Trade Length 9m 2w 6d | Expectancy $55,949.21 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 11,364 | 10,227 | 9,091 | 7,955 | 6,818 | 5,682 | 4,545 | 3,409 | 2,273 | 1,136 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ALRS Alerus Financial Corporation | 66,344 | $1.28M | $2.21M | - | $929,856.48 | 72.79% | -1.481% |
AME Ametek Inc. | 3 | $725.82 | $754.14 | - | $28.32 | 3.9% | -1.327% |
AMG Affiliated Managers Group Inc. | 3 | $1,015.2 | $1,134.39 | - | $119.19 | 11.74% | +0.668% |
AMP Ameriprise Financial, Inc. | 4 | $1,835.04 | $2,214.32 | - | $379.28 | 20.67% | -1.328% |
AMT American Tower Corporation | 20 | $3,271.4 | $3,361.4 | - | $90 | 2.75% | 0.0 |
AMX América Móvil, S.A.B. de C.V. | 88 | $2,287.12 | $2,113.76 | - | -$173.36 | -7.58% | 0.0 |
ARW Arrow Electronics Inc. | 3 | $640.23 | $683.01 | - | $42.78 | 6.68% | +0.361% |
AVEM Avantis Emerging Markets Equity ETF | 179,514 | $17.28M | $16.55M | - | -$727,502.38 | -4.21% | 0.0 |
AVLV Avantis U.S. Large Cap Value ETF | 54 | $4,925.34 | $4,976.64 | - | $51.3 | 1.04% | -1.517% |
AVUV Avantis U.S. Small Cap Value ETF | 113,902 | $14.1M | $14.66M | - | $564,626.6 | 4% | +1.179% |
BIDD iShares International Dividend Active ETF | 71,405 | $1.78M | $2.15M | - | $360,719.85 | 20.22% | -1.573% |
BMY Bristol-Myers Squibb Company | 1,009 | $58,138.58 | $64,727.35 | - | $6,588.77 | 11.33% | +0.817% |
BP BP p.l.c. Sponsored ADR | 100 | $3,695 | $4,121 | - | $426 | 11.53% | 0.0 |
CACC Credit Acceptance Corporation | 1 | $636.74 | $590.27 | - | -$46.47 | -7.3% | -0.38% |
CACI Caci International Inc. | 2 | $926.52 | $995.5 | - | $68.98 | 7.45% | -3.915% |
CGDV Capital Group Dividend Value ETF | 48 | $2,365.44 | $2,377.92 | - | $12.48 | 0.53% | -3.034% |
CRC California Resources Corp | 8 | $422.96 | $420.96 | - | -$2 | -0.47% | +2.473% |
CTSH Cognizant Technology Solutions Corporation | 150 | $5,809.5 | $8,533.5 | - | $2,724 | 46.89% | +1.99% |
CX Cemex S.A.B. de C.V. Sponsored ADR | 93 | $1,116 | $1,050.9 | - | -$65.1 | -5.83% | -2.165% |
DTM Dt Midstream Inc. | 114 | $16,728.36 | $15,152.88 | - | -$1,575.48 | -9.42% | -0.135% |